一种用于预测院外心脏骤停患者目标温度管理后神经学结局的简易风险评分
该回顾性观察性队列研究纳入美国两家大型学术医疗网络中≥18岁、接受目标温度管理的院外心脏骤停存活患者,基于比值比确定5个变量并赋权构建SLANT评分(0-21分),分为中危(0-7)、高危(8-14)、极高危(15-21)三层。Cochran-Armitage趋势检验显示评分对出院时不良神经学结局发生率及院内死亡率均显著(P<0.001)。作者认为该评分便于早期风险评估,但临床效用需进一步研究。
要点
- SLANT评分包含5个变量:初始非可除颤心律、目标温度管理后白细胞计数<4或>12 K/μL、肾上腺素总量≥5 mg、无旁观者心肺复苏、复苏持续时间≥20 min。
- 评分范围0-21分,分为中危(0-7分)、高危(8-14分)、极高危(15-21分)三层。
- 评分对出院时不良神经学结局发生率及院内死亡率均呈显著趋势(Cochran-Armitage趋势检验,P<0.001)。
- 适用人群为≥18岁、接受目标温度管理的院外心脏骤停存活患者,于目标温度管理后早期入院时评估。
- 作者结论:该评分便于风险评估,但临床效用需进一步研究。
适用人群与场景
- 纳入标准:院外心脏骤停存活患者,年龄≥18岁,接受目标温度管理。
- 排除标准:原文未提及。
- 场景:美国两家大型学术医疗网络,目标温度管理后早期入院时评估。
诊断标准与关键阈值
- SLANT评分(范围0-21分)基于5个变量赋权求和:初始非可除颤心律、目标温度管理后白细胞计数<4或>12 K/μL、肾上腺素总量≥5 mg、无旁观者心肺复苏、复苏持续时间≥20 min。
- 风险分层:中危0-7分,高危8-14分,极高危15-21分。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究设计:回顾性观察性队列研究,美国两家大型学术医疗网络。
- 人群:≥18岁、接受目标温度管理的院外心脏骤停存活患者。
- 干预:无。
- 主要结果:SLANT评分对出院时不良神经学结局发生率及院内死亡率均呈显著趋势(Cochran-Armitage趋势检验,P<0.001)。
- 评分构建:基于比值比确定5个变量并赋权,总分0-21分,分中危(0-7)、高危(8-14)、极高危(15-21)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:回顾性设计,仅两家中心,评分临床效用需进一步研究(原文结论)。
对床旁实践的改变
- 原文未提及
指南或共识出处
- Crit Care Med
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Although several risk factors for outcomes of out-of-hospital cardiac arrest patients have been identified, the cumulative risk of their combinations is not thoroughly clear, especially after targeted temperature management. Therefore, we aimed to develop a risk score to evaluate individual out-of-hospital cardiac arrest patient risk at early admission after targeted temperature management regarding poor neurologic status at discharge.
DESIGN: Retrospective observational cohort study.
SETTING: Two large academic medical networks in the United States.
PATIENTS: Out-of-hospital cardiac arrest survivors treated with targeted temperature management with age of 18 years old or older.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Based on the odds ratios, five identified variables (initial nonShockable rhythm, Leucocyte count < 4 or > 12 K/μL after targeted temperature management, total Adrenalin [epinephrine] ≥ 5 mg, lack of oNlooker cardiopulmonary resuscitation, and Time duration of resuscitation ≥ 20 min) were assigned weighted points. The sum of the points was the total risk score known as the SLANT score (range 0-21 points) for each patient. Based on our risk prediction scores, patients were divided into three risk categories as moderate-risk group (0-7), high-risk group (8-14), and very high-risk group (15-21). Both the ability of our risk score to predict the rates of poor neurologic outcomes at discharge and in-hospital mortality were significant under the Cochran-Armitage trend test (p < 0.001 and p < 0.001, respectively).
CONCLUSIONS: The risk of poor neurologic outcomes and in-hospital mortality of out-of-hospital cardiac arrest survivors after targeted temperature management is easily assessed using a risk score model derived using the readily available information. Its clinical utility needed further investigation.
参考来源
- Chen CT, Lin JW, Wu CH, et al. A Simple Risk Score for Predicting Neurologic Outcome in Out-of-Hospital Cardiac Arrest Patients After Targeted Temperature Management. Crit Care Med. 2022. PMID: 34495880. doi:10.1097/CCM.0000000000005266
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。